Skip to main content
Premium Trial:

Request an Annual Quote

ProMetic Closes CA$23M in Financing

NEW YORK, Jan. 9 (GenomeWeb News) - Montreal, Canada-based ProMetic announced today that it has closed CA$23 million in financing after underwriters exercised an over-allotment option that entitlted them to purchase an additional 1.6 million shares over the original 10.5 million they had already purchased as of Dec. 24.

 

The over-allotment transaction is scheduled to close on Jan. 16.

 

The underwriters included Loewen, Ondaatje, McCutcheon, Sprott Securities, Dundee Securities, and Canaccord Capital.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.